KIT and gastrointestinal stromal tumor: 28 Debiec-Rychter Debiec-Rychter M M Sciot Sciot R R Le Cesne Le Cesne A A Schlemmer Schlemmer M M Hohenberger Hohenberger P P KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours Eur J Cancer.